Barrington Research Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $20.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price decreased by research analysts at Barrington Research from $24.00 to $20.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s target price would suggest a potential upside of 20.85% from the company’s current price. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.28 EPS, Q4 2025 earnings at $0.55 EPS, FY2025 earnings at $1.86 EPS, Q1 2026 earnings at $0.37 EPS, Q2 2026 earnings at $0.53 EPS, Q3 2026 earnings at $0.57 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $2.05 EPS and FY2027 earnings at $2.30 EPS.

Several other equities analysts have also recently weighed in on XRAY. Wells Fargo & Company assumed coverage on shares of DENTSPLY SIRONA in a research report on Friday, February 14th. They issued an “equal weight” rating and a $20.00 price target on the stock. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a research report on Friday. Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $23.58.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $16.55 on Friday. The stock has a market capitalization of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The company’s 50-day moving average is $18.83 and its 200-day moving average is $21.50. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA has a 1 year low of $16.21 and a 1 year high of $34.91.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently modified their holdings of the stock. Vise Technologies Inc. purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of DENTSPLY SIRONA by 13.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock worth $10,466,000 after purchasing an additional 65,308 shares during the last quarter. Voloridge Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $24,571,000. Tidal Investments LLC increased its stake in shares of DENTSPLY SIRONA by 15.5% during the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 3,449 shares during the last quarter. Finally, True Wealth Design LLC increased its stake in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 1,950 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.